At Daiichi Sankyo, we are united by a single purpose, to improve lives around the world through innovative medicines. With a legacy of innovation since 1899, a presence in more than 30 countries, and more than 19,000 employees, we are advancing breakthrough therapies in oncology, cardiovascular disease, rare diseases, and immune disorders. Guided by our 2030 vision to "be an innovative global healthcare company contributing to the sustainable development of society", we are shaping a healthier, more hopeful future for patients, their families, and society.
We are currently seeking an R&D Finance Enablement Intern from June 2027 – December 2027. This position works for approximately 37.5 hours per week in the summer and 20 hours per week for the remainder of the internship.
The R&D Finance Enablement team is seeking a motivated undergraduate student to support initiatives that improve how R&D Finance uses data, technology, and standardized processes to support forecasting, accruals, reporting, and decision-making.
This role will provide hands-on experience supporting the continued enhancement of the Project Expense Model (PEM), an initiative designed to standardize and automate R&D forecasting and accrual processes. The intern will also support the development of reports, dashboards, and key performance indicators as part of SAC Wave 3, the next phase of the organization’s implementation of SAP Analytics Cloud (SAC) - a cloud-based platform used to organize, analyze, and present business information.
The position offers an opportunity to work with Finance, Accounting, Procurement, Systems, APMF, Clinical Operations, and other R&D stakeholders while developing practical skills in financial analysis, data visualization, process improvement, and technology-enabled finance.
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
USD$17.23 - USD$58.15

Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need.
For all other inquiries about Daiichi Sankyo such as products or careers, please visit our website www.daiichisankyo.com.